Company intelligence / Profile preview

Orbem

Munich, Bavaria, Germanyorbem.ai ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

Orbem has developed a proprietary AI-powered MRI imaging platform that enables rapid, contactless scanning and classification of organic materials. Its primary commercial application to date is in the agri-food sector—especially egg sorting/sexing—where it improves efficiency and sustainability by identifying fertilization status early. The company’s broader vision includes applying its deep learning/MRI technology to disease detection in healthcare settings. No clinical trial results are reported.

Modalities: Device
Industry: Agriculture & AgTech

Partnerships

Academic institutions such as Technical University of MunichBayFORBayPATEIC Accelerator funding programs

Beyond the preview

Go deeper on Orbem.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orbem.

Explore the full profile